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Abstract
Background: Toluene is one of the most widely abused inhaled drugs due to its acute neurologic effects including
euphoria and subsequent depression. However, dangerous metabolic abnormalities are associated to acute toluene
intoxication. It has been previously reported that rhabdomyolysis and acute hepatorenal injury could be hallmarks of the
condition, and could constitute risk factors for poor outcomes. The objective was to describe the clinical presentation, to
characterize the renal and liver abnormalities, the management and prognosis associated to acute toluene intoxication.
Methods: We prospectively assessed 20 patients that were admitted to a single center’s emergency department from
September 2012 to June 2014 with clinical and metabolic alterations due to acute toluene intoxication.
Results: The main clinical presentation consisted of weakness associated to severe hypokalemia and acidosis. Renal
glomerular injury (proteinuria) is ubiquitous. Biliary tract injury (alkaline phosphatase and gamma-glutamyl transpeptidase
elevations) disproportional to hepatocellular injury is common. Rhabdomyolysis occurred in 80 % of patients, probably
due to hypokalemia and hypophosphatemia. There were three deaths, all female, and all associated with altered mental
status, severe acidosis, hypokalemia and acute oliguric renal failure. The cause of death was in all cases due to cardiac
rhythm abnormalities.
Conclusion: The hallmarks of acute toluene intoxication are hypokalemic paralysis and metabolic acidosis. Liver injury
and rhabdomyolysis are common. On admission, altered mental status, renal failure, severe acidemia and female gender
(not significant in our study, but present in all three deaths) could be associated with a poor outcome, and patients with
these characteristics should be considered to be treated in an intensive care unit.
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Background
Toluene is present in many industrial solvents, and is
responsible for environmental, accidental as well as
intentional intoxications. It is the most widely abused in-
haled volatile drug. It is easily accessible and used in the
fabrication of various products such as paints, paint
thinners, glues, adhesives and cleaning products [43]. As
a recreational drug, toluene is most often inhaled nasally
(glue sniffing, huffing), and produces acute neurological
effects such as euphoria followed by depression [5, 20].
However, almost all organs suffer some form of alter-
ation [20]. Toluene is metabolized by cytochrome p-450
into benzoic acid and hippuric acid, these are excreted by
the kidney [8, 9]. The hallmarks of toluene intoxication
are distal renal tubular acidosis type 1 (RTA-1), classically
described as hyperchloremic with a normal anion-gap, as
well as hypokalemia and muscle paralysis [14].
In a previous case series, we retrospectively studied 22
cases of acute toluene toxicity and found that toluene
inhalation is associated with various severe metabolic
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alterations, including RTA-1, hypokalemic paralysis and
profound metabolic acidemia [12]. We also described el-
evations in alkaline phosphatase (ALP), and in a few pa-
tients, instances of rhabdomyolysis and proteinuria, but
our data were insufficient to determine the relevance of
these findings due to incomplete work-ups. No deaths
were reported in that case series. In this prospective
study, we sought to examine these alterations more thor-
oughly, to examine possible risk factors for poor out-
come and the prognosis.
Methods
We included all patients presenting with acute toluene
intoxication from September 2012 to June 2014. Patients
were enrolled from the Emergency Department of the
University Hospital “Dr. Jose E. González” in Monterrey,
Mexico after the Ethics Committee of the Medical
School of the Autonomous University of Nuevo Leon
approved the study. Written informed consent was ob-
tained from each patient. A case was considered when
the chief complaint (characteristic odor and confirm-
ation of it abuse by the patient) as well as when the
metabolic alterations were attributed to toluene inhal-
ation and after alternative diagnoses were ruled out.
Cases were excluded if the patient was included in the
previous case series (recurrences) [12]. Each case was
identified and assessed by 3 of the authors (RMR, CRCL
and RRG).
Statistical analysis
We used the computer program SPSS, version 17.0
(SPSS Inc., Chicago, Ill., USA) for statistical analyses.
We used Binary Logistic Regression using categorical
co-variables with Confidence Intervals (CI) of 95 % for
odds ratios (OR) to analyze the risk factors associated
with survivors vs. non-survivors. We analyzed correla-
tions between laboratory values using the Pearson cor-
relation coefficient, and a p < 0.05 was considered as
statistically significant.
Results
We identified 20 cases fulfilling criteria for acute toluene
intoxication. Their clinical and demographic characteris-
tics are shown in Table 1. Half of all patients had a pre-
vious history of drug abuse, including cocaine and
marijuana, in addition to toluene inhalation. All patients
or relatives self-reported their recent inhalation of tolu-
ene (paint thinner). The average time that patients had
been using inhalants was 58.6 months (range: 1–260
months, self-reported).
The most common presentation was muscular weakness
or paralysis, followed by altered mental status and gastro-
intestinal complaints including nausea, vomiting and ab-
dominal pain (Table 1). All patients were tachycardic and
tachypneic on admission. A characteristic “toluene” breath
was perceptible in all patients.
The relevant laboratory alterations found are shown in
Table 2. Patients were severely acidotic on admission
(mean plasma venous pH: 7.14 ± 0.09). Blood lactate and
glucose was normal in all cases. Therefore, lactic acidosis
and ketoacidosis were excluded. Mean anion gap was 16 ±
6.9 mmol/L, with 8 out of 20 patients presenting an anion
gap < 12 mmol/L. Patients were also severely hypokalemic,
with a mean potassium level of 2.19 mmol/L ± 1.32 (range:
1.1–4.9 mmol/L). Other electrolytes were also affected, and
hyponatremia (6 cases), hyperchloremia (9 cases) and
hypophosphatemia (12 cases) were quite common.
Serum creatine-phosphokinase (CPK) levels were ele-
vated in 16 cases, with a mean elevation of 6 times the
upper normal limit (1544 ± 1864 U/L) and reaching 6236
U/L in one patient. Liver function tests were normal, ex-
cept for ALP, which was elevated in 15 patients, with a
mean of 152.4 ± 68.9 (range: 67–328 IU/L). Gamma-
glutamyl transpeptidase (GGT) was elevated in all
patients, with a mean of 103.9 ± 66.9 (range: 45–245 IU/
L). Bilirubin was normal in all cases. Serum creatinine
was elevated in 5 cases. EKG abnormalities were com-
mon (Table 1). Ten out of the 15 patients with elevated
ALP and GGT underwent upper abdominal ultrasound.
One patient had biliary sludge, but none had biliary tract
stone disease or dilatation.
Table 1 Patient clinical and demographic data
Patients 20 (100 %)
Female 8 (40 %)
Male 12 (60 %)
Ageç (range) 27.4 (17–43)
Exposure (range) 58.6 (1–260)
Signs and symptoms
Paralysis/weakness 15 (75 %)
Altered mental status 5 (25 %)
GI symptoms 4 (20 %)
Comorbidities
DM 1(5 %)
HIV+ 1(5 %)
EKG findings
Heart Rate 119.1 ± 12.3
ST segment depression 10 (50 %)
AV block (1st degree) 6 (30 %)
U-waves 4 (20 %)
Prolonged QT 4 (20 %)
onths
GI gastrointestinal (nausea, vomiting and abdominal pain), DM diabetes
mellitus, HIV Human immunodeficiency virus, EKG electrocardiographic,
AV Atrioventricular
ç = Years
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On correlation analysis, chloride levels, but not po-
tassium levels, were correlated with blood pH (0.480,
p = 0.04). CPK, ALP and GGT levels did not correlate
with pH, potassium, phosphorus, or creatinine levels,
but an expected strong correlation was found between
ALP and GGT (0.816, p = 0.004). Creatinine levels were
strongly and negatively correlated with blood pH
(−0.711, p = 0.001).
Most patients (18/20) showed some level of metabolic
acidosis and hypokalemia, with established evidence of
renal potassium wasting (urine potassium >20 mmol/L).
Mean urine pH was inappropriately high (pH 6 ± 0.1)
and in 13 cases the anion gap as measured in the urine
was normal, suggesting distal RTA-1. All patients had
some degree of proteinuria, but none reached nephrotic-
range proteinuria in 24-h urine collection.
On admission, all patients received parenteral potas-
sium, with doses ranging from 400 to 800 mEq/day, de-
pending on the severity of hypokalemia. Mean hospital
stay was 4.4 ± 2.1 days, and time to resolution of both
acidemia and hypokalemia was 41.72 ± 20 h. All patients
received in-hospital psychiatric counselling and on dis-
charge were referred to State-sponsored addiction clinics.
Five out of the 20 patients had at least one readmission
(3.2 ± 2.1 months) with identical presentations.
The characteristics of the toluene-related deaths are in
Table 3. All were young females who presented with al-
tered mental status, severe acidemia, hypokalemia,
rhabdomyolysis and acute oliguric renal failure. In the
course of their hospitalization they developed a nodal
heart rhythm and went into cardiac arrest refractory to
advanced cardiopulmonary resuscitation maneuvers. The
risk factors for death we identified in non-survivors vs.
survivors were female sex, serum creatinine ≥ 2.0 mg/dL,
blood (pH) ≤ 7.15 and altered mental status on admis-
sion (Table 4). However, on regression analysis, these
factors did not reach statistical significance. Potassium
levels or presence of altered liver function tests were not
statistically different in non-survivors compared with
survivors.
Discussion
The most common clinical presentation in acute toluene
intoxication was muscular weakness due to hypokalemia
(hypokalemic paralysis, a life-threatening complication
that can lead to respiratory depression), a finding sup-
ported by previous reports [6, 12, 36, 45]. In contrast to
the previous retrospective case series [12], we observed
an alarmingly high mortality rate (15 %), and considering
we gathered a similar number of patients over only
22 months, the incidence of acute toluene intoxication
appears to be higher than previously recognized. Alter-
ations in mental status were relatively infrequent, but it
is worth mentioning that all of the patients who died
presented with this clinical feature. Other interesting
similarities between all fatal cases were female sex, se-
vere acidemia and renal failure on admission. These pa-
tients also had rhabdomyolysis, which could partially
account for oliguric renal failure.
The mechanism of hypokalemic paralysis is an in-
creased ratio between intra- and extracellular potassium
concentrations, which alters membrane polarization and
Table 2 Laboratory alterations associated with toluene toxicity
Laboratory test Value (mean ± SD) Reference-Range
Blood pH (venous) 7.14 ± 0.09 * 7.35 – 7.45
HCO3 (mmol/L) 7.5 ± 4.1 * 24 – 28
Anion Gap (mmol/L) 16 ± 6.9 * 8 – 12
Potassium (mmol/L) 2.1 ± 1.3 * 3.6 – 5.1
Sodium (mmol/L) 136.3 ± 4.3 135 – 145
Chloride (mmol/L) 109.1 ± 7.2 101 – 111
Phosphate (mg/dL) 3.3 ± 3.1 2.5 – 4.5
Calcium (mg/dL) 8.8 ± 1.2 8.4 – 10.2
Magnesium (mg/dL) 2.9 ± 0.6 * 1.8 – 2.5
AST (IU/L) 61.8 ± 59 * 10 – 42
ALT (IU/L) 40.4 ± 21 38 – 126
ALP (IU/L) 152.4 ± 68.9 * 5 – 37
GGT (IU/L) 103.9 ± 66.9 * 0.2 – 1
Total Bilirubin (mg/dL) 0.5 ± 0.2 4.0 – 11.0
WBC (K/uL) 16.9 ± 5.8 * 22 – 262
CPK (U/L) 1544 ± 1864 * 4.6 – 8.0
Urinary pH 6.0 ± 0.1 22 – 262
Urinary potassium (mmol/L) 34.5 ± 32.2 25 – 125
Creatinine (mg/dL) 1.7 ± 1.9 * 0.6 – 1.4
24 h Urinary protein (g) 0.9 ± 0.4 * 0 – 0.15
HCO3 bicarbonate, AST aspartate aminotransferase, ALT alanine
aminotransferase, ALP alkaline phosphatase, GGT Gamma-glutamyl transpeptidase,
WBC white blood cells, CPK creatinephosphokinase, SD standard deviation,
= outside Reference-Range
* = outside reference range
Table 3 Characteristics of deceased patients on admission
Characteristics Patient 1 Patient 2 Patient 3
Age (years) 26 24 26
Sex Female Female Female
Principal symptom AMS AMS AMS
Blood pH (venous) <6.8 7.15 <6.8
Potassium (mmol/L) 1.5 1.5 1.4
CPK (U/L) 2576 656 2676
Creatinine (mg/dL) 3.9 2.3 7.7
EKG findings ST depression ST depression ST depression
T waves AV block
AMS altered mental status, CPK creatinephosphokinase, EKG
electrocardiography, AV atrioventricular
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thereby alters the function of excitable tissues such as
nerve and muscle [2]. We found inappropriately high
urinary levels of potassium in 15 patients (urine potas-
sium >20 mmol/L), confirming that potassium wasting
is another mechanism responsible for hypokalemia in
toluene intoxication. Inadequate intake, gastrointestinal
losses, intracellular shift and diuretic use are all common
causes of hypokalemia and should be included in the dif-
ferential diagnosis. Intracellular shift can be secondary
to insulin excess, thyrotoxic periodic paralysis, among
others. A limitation of our study is the lack of objective
studies that validated the diagnosis of toluene intoxica-
tion, such as hippuric acid measurements in urine or the
identification of other toluene byproducts in urine or
serum this due to the fact that they were not assays
available for these metabolites in our country. However,
in our study, toluene intoxication diagnosis was estab-
lished by a compatible clinical presentation and either
the patients or relatives statement of intentional toluene
inhalation. Besides toluene intoxication, other conditions
may present with secondary RTA, hypokalemia and
paralysis, such as Sjögren’s syndrome, hypothyroidism
and systemic lupus erythematosus were discarded [15,
33, 34].
An association between distal RTA-1 and toluene in-
halation was first described in 1974 [46]. Since then,
the acid base abnormalities caused by toluene intoxica-
tion have been well characterized. Distal RTA-1, classic-
ally described as a hyperchloremic metabolic acidosis
with hypokalemia, is characterized by an inability to
lower urine pH despite severe acidemia and minimal
HCO3 wastage. The main proposed mechanisms in
toluene-induced distal RTA-1 is an inability of the dis-
tal tubule to excrete hydrogen ions as ammonium, me-
diated by decreased proton conductance through the
active conduction pathway [7], as well as overproduc-
tion of hippuric acid by toluene metabolism [14].
Unfortunately, measurements of urinary fractional ex-
cretion of bicarbonate or urine chloride to determine
urinary anion gap were not obtained. These investiga-
tions would be useful in understanding the underlying
pathophysiology. Irrespective of the mechanisms in-
volved, severe acidemia seems to be associated with a
poor prognosis.
Toluene might cause both glomerular and tubular
damage. Fanconi syndrome and hematuria have all been
previously associated with toluene intoxication [14, 37,
41, 45]. We found that all patients showed some degree
of proteinuria, which supports the hypothesis of Fan-
coni syndrome as characteristic of this entity, although
24 h levels of protein did not reach nephrotic-range
levels. Cross-sectional studies of workers chronically
exposed to toluene and other organic solvents found an
increased urinary albumin excretion compared to con-
trols [50]. Among industrial solvents, toluene exposure
was found to confer the greatest risk for progression to
end-stage renal disease in patients with established
glomerulonephritis [29]. Toluene has also been associ-
ated to direct induction of acute tubular necrosis and
acute oliguric renal failure [25]. Vomiting, dehydration,
tubular injury and rhabdomyolysis are all possible
causes of acute renal failure in toluene intoxication,
and this complication seems to carry an ominous
prognosis.
Rhabdomyolysis, occurring either by direct toluene
muscular injury or prolonged immobility [45], was an-
other abnormality found in the majority of patients
(80 %). None of our patients reported periods of immo-
bility and the elevated values of CPK we observed, sug-
gest direct muscular injury. The major causes of
rhabdomyolysis include trauma, ischemia, drugs, toxins
and metabolic disorders. Electrolyte disturbances, not-
ably hypokalemia and hypophosphatemia, are known
causes of rhabdomyolysis that might play important
roles in the setting of toluene intoxication. Muscular
phosphate depletion in severe hypophosphatemia im-
pairs the biochemical pathways of ATP production and
alters the affinity of oxygen for haemoglobin in erythro-
cytes, also leading to muscle injury [18, 31].
Frank rhabdomyolysis is thought to occur mainly
when serum potassium levels are < 2.0 mmol/L [18, 32].
In our series, the 12 patients presenting with a serum
potassium < 2.0 mmol/L, all had elevated CPK, whereas
serum potassium levels were > 2.0 mmol/L in all 4 pa-
tients with normal CPK values. Hypophosphatemia was
also ubiquitous in patients with rhabdomyolysis. Acid-
osis itself has been proposed as a contributing factor in
the development of rhabdomyolysis in hypokalemia [16,
26], but in vivo animal studies failed to show that either
chronic or acute acidosis increases myoglobin renal tox-
icity [27]. Therefore, direct toluene muscular injury and
electrolyte abnormalities appear to be the main causes of
rhabdomyolysis in acute toluene intoxication.
Chronic toluene abuse has been associated with liver
damage characterized by increases in transaminases and
ALP [10, 11]. In our previous series, the most common
alteration in liver function tests was an elevated ALP,
but GGT levels were not measured and diagnostic
Table 4 Risk factors for death in non-survivors vs. survivors
Factor Unadjusted OR (CI 95 %) P value
Sex (Female) 0.60 (0.14–2.51) 0.48
pH≤ 7.15a 0.37 (0.10–1.41) 0.14
Creatinine≥ 2.0 mg/dLa 1.50 (0.25–8.98) 0.65
Altered mental statusa 1.50 (0.25–8.98) 0.65
OR Odds ratio, CI Confidence Interval
a: On admission
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imaging procedures to study the biliary tract were not
done. Although there is evidence that chronic glue sniff-
ing and severe acidosis (including RTA-1) are associated
with osteomalacia and increased bone resorption ([17];
Fulop et al., 2004; [48]), it is unlikely that elevated levels
of ALP are originated from bone in toluene intoxication.
First of all, in both non-toluene causes of RTA-1 (Sjög-
ren’s syndrome) and severe acidosis (diabetic ketoacido-
sis), ALP levels have actually been found to be decreased
[21, 48]. Serum calcium levels were also normal. More-
over, we found that GGT, a more specific marker of bil-
iary tract injury, was consistently elevated, in addition to
the absence of concomitant alterations in ultrasound
findings or elevations in serum total bilirubin levels.
These findings suggest that toluene leads to direct biliary
tract injury. Interestingly, ALP was not elevated and
GGT was only mildly elevated in those patients who
died. Liver injury in acute toluene intoxication appears
to be mild and not to contribute to mortality.
The hepatotoxic potential of toluene has been recog-
nized for some time. In 1971, O’Brien et al. described
the case of a glue sniffer who was admitted with renal
and hepatic failure and persisted with elevated ALP
levels after 7 days of supportive treatment [39]. In 102
patients exposed to car paint, none showed alterations
in any liver enzyme, including GGT and ALP [35]. How-
ever, animal studies have conclusively established the
hepatotoxic effects of toluene inhalation. Subacute tolu-
ene exposure leads to liver balloon degeneration and
liver function test abnormalities trough a variety of
mechanisms, including increased oxidative stress and
CYP2E1 dependent chlorzoxazone hydroxylation [38,
47]. Interestingly, in a rat study of toluene exposure in
breathing air for a period of 4 weeks, the only liver ab-
normality found was increased ALP [42]. This is consist-
ent with reports of increased ALP as the only liver
alteration found in volatile-substance abusing street chil-
dren (Olgar et al., 2008), as well as with our results.
Arrhythmia [45], ST wave changes related to hypokal-
emia, and even acute myocardial infarction have been de-
scribed in association with toluene intoxication [13].
Severe hypokalemia decreases conduction velocity, in-
creases automaticity and shortens the refractory period,
leading to ST wave changes, atrioventricular block and
cardiac arrest [19]. Chronic toluene abusers also have lon-
ger QT and corrected QT wave duration and dispersion
compared to controls [4]. The development of cardiac ar-
rhythmias is indeed the principal cause of death following
inhalant abuse [22]. Severe acidosis could have contrib-
uted to refractory cardiac arrest. Cardiovascular monitor-
ing and urgent correction of electrolytic and metabolic
alterations are critical to prevent cardiac complications.
There is evidence suggesting that the female sex demon-
strates distinct electrocardiographic patterns of ventricular
repolarization associated with a longer rate-corrected QT
interval, in both humans and animals [1]. Androgen de-
ficiency could account for these changes, as it leads to
alterations in rectifier potassium and calcium current
densities in ventricular repolarization that provokes a
prolongation of action potential and QTc interval [28,
30]. These hormonal differences make women more
susceptible to drug-induced arrhythmia such as Long
QT syndrome, Torsade de Pointes, among others [1,
30]. We speculate that this could account for the exclu-
sively female mortality due to conduction defects we
observed in this study.
The treatment of acute toluene toxicity consists in cor-
rection of the electrolytic and acid base alterations. Ag-
gressive potassium replacement, hydration and close
monitoring of the cardiac rhythm are essential [2, 3]. Re-
spiratory depression due to paralysis is rare, and if
present, it requires prompt intubation and mechanical
ventilation. Management of hypokalemia should follow
published guidelines [23, 49], and large doses are often
needed. In our experience, the placing of a central line is
essential for adequate potassium repletion.
On the basis of our findings, specific recommendations
can be made. Patients should be evaluated for rhabdo-
myolysis. Acute oliguric renal failure should be treated ag-
gressively and in case of nonreversal, dialysis might be
promptly considered [24]. Acute liver injury does not ap-
pear to be clinically relevant. Urgent cardiologic consult-
ation and evaluation are needed in most cases. The role of
bicarbonate therapy remains unclear, and even though a
specific recommendation cannot be made in severe cases
its use might be considered [44]. After stabilization, great
care should be placed on preventive measures, including
patient education, rehabilitation and follow-up.
Conclusions
Toluene intoxication due to intentional inhalation is a
common admission diagnosis in Mexico and it can lead
to death. The acute neurological symptoms are accom-
panied by severe metabolic alterations, as well as organ
injury and dysfunction. The hallmarks of toluene intoxi-
cation are hypokalemic paralysis and metabolic acidosis.
Liver injury and rhabdomyolysis are common. Altered
mental state on admission, renal failure, severe acidemia
and female gender could be associated with a poor out-
come (not significant in our study), and patients with
these characteristics should be treated in an intensive
care unit. Further studies should establish an optimal
treatment regimen, and great effort should be placed in
preventive measures.
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